| The International
Federation of Pharmaceutical Manufacturers Associations (IFPMA)
The mission of the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) is to represent, through its member associations, the international pharmaceutical and vaccine industry engaged in the research and development and quality manufacturing of innovative therapeutic and preventive medicines and vaccines. The IFPMA represents over 55 national industry associations from both developed and developing countries. Companies in membership of the IFPMA are the major global research-based pharmaceutical and vaccine companies. The IFPMA strives to create a global environment that fosters innovation in preventing and curing diseases, and regulation that expedites approval of new chemical and biological treatments for patients and assures the genuine quality of vaccines and medicines. In the current research and development
pipeline, industry has over 100 medicines and vaccines for
infectious diseases, many of which are particularly relevant to
the developing world, including HIV/AIDS, malaria, tuberculosis,
dengue, acute respiratory tract infections, diarrheal diseases
and several others. The IFPMA’s Role in GAVI The IFPMA is a full partner in GAVI. The vaccine-producing members of the IFPMA have a long-standing legacy of working with international public health agencies to ensure the enhancement of health for children globally, through immunization. Through the alliance, member partners will address ways to accelerate the development and introduction of new vaccines specifically needed by developing countries. The vaccine industry members of the IFPMA will, in cooperation with their GAVI partners, work to ensure accessibility to vaccines for all the world’s children with a particular focus on the poorest people and countries. The specific vaccine industry partners involved in GAVI are those that produce the greatest share of the global vaccine supply. They are: Aventis
Pasteur
|
